Radiopharmaceuticals And Chemical Probes
Tag
Sep 14, 2022
![<strong>New CPDC spinout company aims to become global leader in developing and distributing radiopharmaceuticals</strong>](https://oicr.on.ca/wp-content/uploads/2022/09/NRB-Picture.png)
New CPDC spinout company aims to become global leader in developing and distributing radiopharmaceuticals
Jun 16, 2020
![OICR joins European consortium to ‘enable and unlock biology in the open’](https://oicr.on.ca/wp-content/uploads/2020/06/Richard_Marcellus.jpg)
OICR joins European consortium to ‘enable and unlock biology in the open’
Aug 02, 2018
![Ontario centre attracts national attention for probe research, development and commercialization](https://oicr.on.ca/wp-content/uploads/2018/08/CPDC.jpg)
Ontario centre attracts national attention for probe research, development and commercialization
Oct 04, 2017
![FACIT Portfolio Company Fusion Pharmaceuticals Closes US$46M Oversubscribed Series A](https://oicr.on.ca/wp-content/uploads/2016/03/fusion.jpg)
FACIT Portfolio Company Fusion Pharmaceuticals Closes US$46M Oversubscribed Series A
Feb 10, 2017
![How chemical probes can boost cancer research](https://oicr.on.ca/wp-content/uploads/2016/06/david-lab.jpg)
How chemical probes can boost cancer research
Mar 16, 2016
![FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic](https://oicr.on.ca/wp-content/uploads/2016/03/fusion.jpg)
FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic
Dec 16, 2015
![FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics](https://oicr.on.ca/wp-content/uploads/2016/11/facit.png)
FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.